Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, United Kingdom.
Mol Oncol. 2010 Jun;4(3):174-91. doi: 10.1016/j.molonc.2010.04.011. Epub 2010 May 21.
Genetic and lifestyle/environmental factors are implicated in the aetiology of breast cancer. This review summarizes the current state of knowledge on rare high penetrance mutations, as well as moderate and low-penetrance genetic variants implicated in breast cancer aetiology. We summarize recent discoveries from large collaborative efforts to combine data from candidate gene studies, and to conduct genome-wide association studies (GWAS), primarily in breast cancers in the general population. These findings are compared with results from collaborative efforts aiming to identify genetic modifiers in BRCA1 and BRCA2 carriers. Breast cancer is a heterogeneous disease, and tumours from BRCA1 and BRCA2 carriers display distinct pathological characteristics when compared with tumours unselected for family history. The relationship between genetic variants and pathological subtypes of breast cancer, and the implication of discoveries of novel genetic variants to risk prediction in BRCA1/2 mutation carriers and in populations unselected for mutation carrier status, are discussed.
遗传和生活方式/环境因素与乳腺癌的病因有关。这篇综述总结了目前关于罕见高外显率突变以及中度和低度外显率遗传变异与乳腺癌病因的知识现状。我们总结了最近从大型合作研究中得出的发现,这些研究旨在结合候选基因研究的数据,并进行全基因组关联研究(GWAS),主要针对普通人群中的乳腺癌。这些发现与旨在确定 BRCA1 和 BRCA2 携带者中遗传修饰因子的合作研究的结果进行了比较。乳腺癌是一种异质性疾病,与未选择家族史的肿瘤相比,BRCA1 和 BRCA2 携带者的肿瘤显示出明显不同的病理特征。遗传变异与乳腺癌病理亚型之间的关系,以及发现新的遗传变异对 BRCA1/2 突变携带者和未选择突变携带者状态的人群的风险预测的意义,都进行了讨论。